White Blood Cell Counts and Onset of Cardiovascular Diseases: a CALIBER Study

NCT02014610 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800000

Last updated 2013-12-18

No results posted yet for this study

Summary

The complete blood count is a commonly performed blood test, and previous small studies have suggested that the counts of some types of white blood cell in the complete blood count may be related to the onset of cardiovascular diseases such as stroke and heart attack. This is of interest because this information may help to predict strokes or heart attacks and may guide new therapies which act on white blood cells to reduce the risk of cardiovascular disease.

The hypothesis is that counts of particular types of white blood cell are associated with a range of cardiovascular diseases.

Conditions

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER
  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV
  • Medical Research Council

    collaborator OTHER_GOV
  • London School of Hygiene and Tropical Medicine

    collaborator OTHER
  • University College, London

    lead OTHER

Principal Investigators

  • Anoop D Shah, MRCP · University College, London

  • Harry Hemingway, FRCP · University College, London

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1997-01-31
Primary Completion
2013-12-31
Completion
2014-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02014610 on ClinicalTrials.gov